Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,221 | 237 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $663.48 | 40 | $0 (2024) |
| Lilly USA, LLC | $612.04 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $457.24 | 23 | $0 (2024) |
| Novo Nordisk Inc | $428.42 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $181.28 | 6 | $0 (2024) |
| Gilead Sciences, Inc. | $154.25 | 10 | $0 (2022) |
| Abbott Laboratories | $150.26 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $123.46 | 5 | $0 (2024) |
| Allergan, Inc. | $123.14 | 7 | $0 (2020) |
| PFIZER INC. | $106.01 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,031 | 51 | Novo Nordisk Inc ($195.62) |
| 2023 | $940.65 | 52 | GlaxoSmithKline, LLC. ($222.02) |
| 2022 | $710.70 | 42 | Lilly USA, LLC ($159.86) |
| 2021 | $381.78 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($89.86) |
| 2020 | $485.82 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($113.59) |
| 2019 | $439.81 | 28 | Gilead Sciences, Inc. ($104.42) |
| 2018 | $213.70 | 12 | GlaxoSmithKline, LLC. ($45.51) |
| 2017 | $18.00 | 1 | Noden Pharma USA Inc ($18.00) |
All Payment Transactions
237 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.83 | General |
| 12/12/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.30 | General |
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Endocrinology | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Biological | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: VACCINE | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Biological | ||||||
| 08/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.65 | General |
| 08/19/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Neuromodulation | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: VACCINES | ||||||
| 08/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.60 | General |
| 07/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 906 | 1,228 | $110,468 | $40,832 |
| 2022 | 19 | 951 | 1,266 | $117,270 | $42,174 |
| 2021 | 25 | 1,092 | 1,430 | $133,904 | $47,201 |
| 2020 | 23 | 948 | 1,271 | $108,927 | $35,118 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 194 | $39,964 | $15,257 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $20,412 | $8,195 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 131 | $18,209 | $7,827 | 43.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 196 | $1,764 | $1,621 | 91.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $3,660 | $1,511 | 41.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 74 | 97 | $5,529 | $1,233 | 22.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 74 | 96 | $3,456 | $787.55 | 22.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $1,540 | $680.02 | 44.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 32 | 32 | $2,496 | $605.44 | 24.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 50 | 63 | $2,079 | $479.43 | 23.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 24 | 30 | $2,130 | $477.34 | 22.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 40 | 47 | $2,115 | $465.75 | 22.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 48 | $1,968 | $437.92 | 22.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 22 | 24 | $1,464 | $377.91 | 25.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 26 | 43 | $1,032 | $232.06 | 22.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 27 | 44 | $968.00 | $213.36 | 22.0% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 13 | 14 | $546.00 | $175.00 | 32.1% |
| 83540 | Iron level | Office | 2023 | 13 | 14 | $392.00 | $88.76 | 22.6% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 21 | 22 | $264.00 | $58.30 | 22.1% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 11 | 11 | $242.00 | $55.88 | 23.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 13 | 17 | $238.00 | $52.87 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 236 | $48,616 | $18,448 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $19,116 | $7,794 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 136 | $18,904 | $7,672 | 40.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 89 | 115 | $6,555 | $1,522 | 23.2% |
About Dr. Bruce Page, MD
Dr. Bruce Page, MD is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972567378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Page, MD has received a total of $4,221 in payments from pharmaceutical and medical device companies, with $1,031 received in 2024. These payments were reported across 237 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,221).
As a Medicare-enrolled provider, Page has provided services to 3,897 Medicare beneficiaries, totaling 5,195 services with total Medicare billing of $165,324. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 04/13/2006
- Last Updated 01/13/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972567378
Products in Payments
- JARDIANCE (Drug) $562.16
- BEXSERO (Biological) $275.93
- MOUNJARO (Drug) $242.31
- TRELEGY ELLIPTA (Drug) $195.71
- EMGALITY (Drug) $165.44
- Ozempic (Drug) $152.89
- Veozah (Drug) $123.46
- UBRELVY (Drug) $114.85
- SHINGRIX (Biological) $99.76
- Kerendia (Drug) $97.45
- QUVIVIQ (Drug) $95.95
- Heplisav-B (Drug) $92.52
- Vascepa (Drug) $87.36
- INSPIRE (Device) $81.12
- PNEUMOVAX 23 (Biological) $70.47
- AJOVY (Biological) $67.84
- Aimovig (Biological) $65.88
- PROCLAIM (Device) $63.59
- Xofluza (Drug) $51.74
- Cologuard Collection Kit (Device) $50.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768